A novel ceftazidime-hydrolysing extended-spectrum b-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop Objectives: To characterize a novel ceftazidime-hydrolysing CTX-M mutant, designated CTX-M-54, produced by Klebsiella pneumoniae clinical isolate BDK0419 and to investigate its genetic environment.
Introduction
CTX-M-type extended-spectrum b-lactamases (ESBLs), the most widespread enzymes among non-TEM and non-SHV plasmidmediated ESBLs, were initially reported in the second half of the 1980s in Europe. 1 As the designation 'CTX' indicates, these enzymes preferentially hydrolyse cefotaxime but not ceftazidime. CTX-M-16 and CTX-M-27 harbour an Asp!Gly substitution at position 240. [2] [3] [4] CTX-M-19 (derived from CTX-M-18) and CTX-M-23 (derived from CTX-M-19) harbour a Pro!Ser and a Pro!Thr substitution at position 167 in the omega loop, respectively. 5, 6 This report identifies another ceftazidime-hydrolysing CTX-M mutant, designated CTX-M-54. CTX-M-54 differed from CTX-M-3 only by the substitution Pro-167!Gln and is the third CTX-M enzyme harbouring an amino acid substitution at position 167 after CTX-M-19 and CTX-M-23.
Materials and methods

Bacterial strains
Klebsiella pneumoniae clinical isolate BDK0419 was identified with the API 20E system (bioMérieux, Marcy l'Etoile, France). Escherichia coli BL21(DE3) was the host for cloning experiments, and E. coli J53 Azide R was used as a recipient strain for conjugative transfer. E. coli ATCC 25933 was used as an MIC reference strain.
Antimicrobial susceptibility testing
Antibiotic-containing discs (BBL, Cockeysville, MD, USA) were used for routine antibiograms by disc diffusion assay according to the recommendations of the CLSI. 7 The double-disc synergy test was carried out on Mueller-Hinton agar (Difco Laboratories, Detroit, MI, USA) with discs of ceftazidime, cefotaxime and aztreonam, each containing 30 mg of the drug, placed at distances of 20 mm (centre to centre) from a disc containing amoxicillin-clavulanic acid (20 mg/10 mg) in the centre of the plate. 8 MICs were determined by the agar dilution method with Mueller-Hinton agar with an inoculum of 10 4 cfu. 9 MICs of b-lactams were determined alone or in combination with a fixed concentration of clavulanic acid (4 mg/L).
PCR experiments
Plasmid DNA of K. pneumoniae BDK0419 was extracted as described previously, 10 and this DNA was used as a template in PCR experiments with a series of primers designed for the detection of class A b-lactamase genes and their extended-spectrum derivatives: bla TEM , bla SHV , bla CTX-M-1 , bla CTX-M-2 , bla CTX-M-8 , bla CTX-M-9 , bla PER-1 , bla VEB-1 , bla IBC/GES and bla TLA ( Table 1 ). The PCR products were subjected to direct sequencing by the dideoxynucleotide chain-termination method with an automatic DNA sequencer (ABI 3700, Perkin-Elmer, Foster City, CA, USA). Both strands of the PCR products were sequenced twice.
The genetic organization of the bla CTX-M-54 gene was investigated by PCR and sequencing of the regions surrounding this gene. The internal ISEcp1 forward primers (TN1-F and BTN-F) and CTX-M-1 reverse primers (CTX-M-1R and FM-1R) were used to investigate the promoter regions of the bla CTX-M-54 gene. PCR primers corresponding to sequences upstream (pemK and ISEcp1) and downstream (IS903) of the bla CTX-M-54 gene were also used (Table 1) . Table 1 . Sequences of the primers used in the study
PCR target
Primer name Primer sequence
Mating-out assays
Conjugation experiments were carried out between K. pneumoniae BDK0419 (donor) and azide-resistant recipient strain E. coli J53 on Mueller-Hinton agar plates. 11 Transconjugants were selected on Mueller-Hinton agar plates supplemented with ceftazidime (2 mg/L) and sodium azide (100 mg/L).
Purification of CTX-M-54 b-lactamase
The PCR product obtained with primers CTX-M-54 pcrF (5 0 -GG GAA TTC CAT ATG GTT AAA AAA TCA CTG CG-3 0 ; NdeI site underlined) and CTX-M-54 pcrR (5 0 -CCG CTC GAG CAA ACC GTC GGT GAC GAT TTT-3 0 ; XhoI site underlined) was purified with a QIAquick column (Qiagen, Courtaboeuf, France) and ligated in the NdeI and XhoI sites of plasmid pET30a (Novagen, Milan, Italy). It was then subjected to confirmatory sequencing. The expression vector constructed, named pET30a-CTX-M-54, was introduced into E. coli BL21(DE3) competent cells. E. coli BL21(DE3) carrying plasmid pET30a-CTX-M-54 was cultured at 37 C in 1 L of LB broth supplemented with kanamycin (50 mg/L). Isopropyl-b-Dthiogalactopyranoside (final concentration, 0.4 mM) was added when the culture reached an OD 600 of 0.6, and the culture was incubated overnight at 20
C. The cells were harvested by centrifugation and were resuspended in 50 mL of buffer A [50 mM Tris (pH 7.0), 500 mM NaCl, 10 mM imidazole] and were then disrupted by microfluidizer at 15 000 psi. The cell lysate was finally centrifuged at 15 000 g for 40 min to remove cell debris. The cleared supernatant was loaded onto an Ni-NTA column (XK16, Amersham-Pharmacia-Biosciences, Milan, Italy) pre-equilibrated with buffer A. After loading, buffer B [50 mM Tris (pH 7.0), 500 mM NaCl, 25 mM imidazole] was used to wash the column. The b-lactamase was eluted with a linear gradient of imidazole (25-300 mM in 1 h). The fractions containing nitrocefin-hydrolysing activity and purity-confirmed by SDS-PAGE were pooled and dialysed with buffer C [50 mM Tris (pH 7.0), 300 mM NaCl without imidazole]. The final protein concentration was 0.315 mg/mL (purity >>90%).
Isoelectric focusing (IEF)
To determine the isoelectric point (pI), 5 mL of the condensed supernatant containing b-lactamase was loaded onto a Novex IEF Gel (pH 3-10; Invitrogen, Carlsbad, CA, USA) with an Xcell surelock Mini-Cell system (Invitrogen). Running conditions were 100 V constant for 1 h, 200 V constant for 1 h and 500 V for 30 min. 11 The pI of the b-lactamase was measured by staining the gel with a 0.05% solution of nitrocefin (Oxoid, Basingstoke, UK).
Kinetic measurements
Purified b-lactamase was used for kinetic measurements performed at 30 C with 100 mM sodium phosphate buffer (pH 7.0) with a Cary 300 Bio UV-visible spectrophotometer (Varian Inc., Palo Alto, CA, USA). Wavelengths of 235 nm for benzylpenicillin (Sigma, St Louis, MO, USA); 236 nm for ampicillin (Sigma); 318 nm for aztreonam (Sigma); 482 nm for nitrocefin (Oxoid); 260 nm for ceftazidime (Sigma), cefotaxime and cefuroxime (Sigma); 265 nm for cefalothin (Sigma); and 260 nm for cefaloridine (Sigma) were used. Extinction coefficients of each antibiotic substrate used in the spectrophotometric assays were same as described previously. 4 The steady-state kinetic parameters (K m and k cat ) were determined under initial-rate conditions using Lineweaver-Burk plot.
Nucleotide sequence accession number
The nucleotide sequence data reported in this paper are available in the GenBank nucleotide database under accession number DQ303459.
Results
Description of the clinical isolate K. pneumoniae BDK0419 was isolated from a sputum specimen of a female patient hospitalized at an intensive care unit in a tertiary-care hospital in Sungnam, Korea, in May 2004, for hypertensive intracranial haemorrhage and pulmonary oedema. Strain BDK0419 exhibited resistance to ampicillin, ampicillinsulbactam, piperacillin, ceftazidime, amikacin, gentamicin and tobramycin and susceptibility to piperacillin-tazobactam, cefoxitin, cefotaxime, cefepime, aztreonam, imipenem, ciprofloxacin and trimethoprim/sulfamethoxazole. The strain exhibited a positive double-disc synergy test, thus indicating the production of ESBLs.
PCR and sequencing of the b-lactamase genes PCR amplifications using primers specific for ESBL-encoding genes revealed that K. pneumoniae BDK0419 possessed both bla SHV and bla CTX-M-1 -type genes. Sequence of the bla SHV PCR amplicon with K. pneumoniae BDK0419 was 100% identical to the bla SHV-2a sequence. Sequence data of the bla CTX-M-1 -type gene indicate an open reading frame of 873 bp, corresponding to a putative protein of 291 amino acids. The bla CTX-M-1 -type gene differed from bla CTX-M-3 , the nearest CTX-M neighbour, by only a Pro (CCG) to Gln (CAG) substitution at Ambler position 167. As this substitution has not previously been described in the CTX-M-type b-lactamases, the enzyme from K. pneumoniae BDK0419 appears to be a novel b-lactamase and has been designated CTX-M-54.
Genetic environment of bla CTX-M-54
An ISEcp1 insertion sequence, comprising an intact tnpA gene, was located 128 bp upstream of bla CTX-M-54 . ISEcp1 possesses two imperfect inverted repeats (IRs), the left IR (IRL, CCTA-GATTCTACGTCAGT) and the right IR (IRR, ACACACGTG-GAATTTAGG), made of 18 bp with 14 of these 18 bp being complementary. A putative promoter consisting of the -10 (TACAAT) and -35 (TTGAA) regions, which drives bla CTX-M-54 transcription, was observed within the 3 0 non-coding sequence of ISEcp1. To identify further DNA sequences surrounding the bla CTX-M-54 gene, several long-range PCR experiments were performed using a series of primers. The upstream region of the ISEcp1 insertion sequence contained the pemK gene. The pemK protein, the pemK gene product, is supposed to inhibit the growth of host cells that have lost the pem + plasmid. 12 One-hundred and twenty-four nucleotides from the stop codon, the bla CTX-M-54 gene was flanked by a IS903-like element (Figure 1 ).
Transfer of resistance to ceftazidime K. pneumoniae BDK0419 contained three plasmids with molecular sizes of 21 (pBDK0419), 3.5 and 3 kbp. The strain transferred pBDK0419 containing both bla SHV-2a and bla CTX-M-54 genes to the E. coli J53 Azide R recipient by mating experiments.
b-Lactam susceptibility
Agar dilution MIC testing confirmed that the K. pneumoniae BDK0419 was resistant to ampicillin and ceftazidime, intermediate to aztreonam, and susceptible to cefoxitin, cefotaxime, cefepime and imipenem (Table 2) . Notably, the MIC of ceftazidime for this strain was 16-fold higher than that of cefotaxime. The b-lactam resistance phenotypes of the transconjugant (E. coli trcBDK0419) and E. coli BL21(DE3) carrying plasmid pET30a-CTX-M-54 were almost identical to those of the K. pneumoniae BDK0419 (i.e. the MICs of ceftazidime were 16-fold higher than those of cefotaxime). Clavulanic acid restored the activities of ceftazidime in all three strains.
IEF analysis
IEF of the sonic extract of E. coli trcBDK0419 showed two bands with pI values of 7.6 and 8.0. IEF of the partially purified b-lactamase of E. coli BL21(DE3) carrying plasmid pET30a-CTX-M-54 revealed a band with a pI value of 8.0. The relative molecular mass of CTX-M-54, determined by SDS-PAGE analysis, was 28 kDa (data not shown).
Kinetic studies
The kinetic parameters for the CTX-M-54 b-lactamase showed that it had activity against most b-lactams including benzylpenicillin, cefaloridine, cefuroxime and cefotaxime (Table 3) . There was a discrepancy between MIC results and the kinetic parameters of the enzyme against ceftazidime and cefotaxime. ).
Discussion
The strain BDK0419 contained a transferable plasmid with a molecular size of 21 kbp (pBDK0419) that carries both bla SHV-2a and bla CTX-M-54 b-lactamase genes, along with two other plasmids. CTX-M-54 had a P167Q substitution within the omega loop region of class A b-lactamases compared with the sequence of CTX-M-3. Amino acid substitutions at this position of CTX-M-type b-lactamases have been associated with expansion of activity towards ceftazidime. 13 MICs of ceftazidime for all K. pneumoniae BDK0419, the transconjugant (E. coli trcBDK0419) and E. coli BL21(DE3) carrying plasmid pET30a-CTX-M-54 were 16-fold higher than those of cefotaxime. These results indicate that CTX-M-54 preferentially hydrolyses ceftazidime but not cefotaxime. However, the kinetic parameters of CTX-M-54 against ceftazidime revealed a low catalytic efficiency. A similar discrepancy between MIC results and kinetic data has been reported in CTX-M-19, ascribed to a rapid loss of the activity of the enzyme caused by instability of the protein. 5 The bla CTX-M-54 gene was flanked upstream by an ISEcp1 insertion sequence and downstream by an IS903-like element. The bla CTX-M genes belonging to the CTX-M-1, CTX-M-2 and CTX-M-9 clusters are associated with ISEcp1-like insertion sequences. 14 The bla CTX-M-17 and bla CTX-M-19 genes are also associated with IS903-like elements. 14, 15 ISEcp1-like insertion sequences may play a role in the mobilization of the bla CTX-M genes by a transcriptional mechanism by recognizing a variety of DNA sequences as right IRs. However, the role of IS903-like elements in the mobilization process of the bla CTX-M genes has not yet been demonstrated.
The present work shows once again that novel CTX-M enzymes with an expanded activity towards ceftazidime through a single amino acid substitution can be identified from clinical isolates. Thus, detection of CTX-M enzymes can no longer be based solely on the resistance phenotypes of clinical isolates towards ceftazidime and cefotaxime.
